Hbk Sorce Advisory LLC Fate Therapeutics Inc Transaction History
Hbk Sorce Advisory LLC
- $3.02 Billion
- Q3 2025
A detailed history of Hbk Sorce Advisory LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 11,620 shares of FATE stock, worth $15,687. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,620
Previous 11,620
-0.0%
Holding current value
$15,687
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FATE
# of Institutions
152Shares Held
83.4MCall Options Held
179KPut Options Held
13.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$17.4 Million1.75% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$13.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$11.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.54MShares$6.13 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.4MShares$4.59 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $131M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...